Article Sidebar

PDF
Date Published: 01/11/2023
Abstract Views: 111
Views PDF: 77
DOI: https://doi.org/10.51298/vmj.v531i1B.7017
Issue
Vol. 531 No. 1B (2023)
Section
Các bài báo
How to Cite
Nguyễn , T. N. N. ., Đặng , T. M. N. ., & Nguyễn , T. M. . (2023). PARACLINICAL CHARACTERISTICS OF OVARIAN TERATOMA PATIENTS. Vietnam Medical Journal, 531(1B). https://doi.org/10.51298/vmj.v531i1B.7017

PARACLINICAL CHARACTERISTICS OF OVARIAN TERATOMA PATIENTS

Thị Như Ngọc Nguyễn 1, Thị Minh Nguyệt Đặng 1, Tuấn Minh Nguyễn 1,
1 HMU

Main Article Content

Abstract

Objective: Paraclinical characteristics of surgically treated ovarian teratoma patients. Subjects and Methods: This cross-sectional retrospective study enrolled 252 patients diagnosed with and surgically treated for ovarian teratoma from January 2022 to December 2022 at Hanoi Obstetrics and Gynecology Hospital. Results: The mean age was 30.42 years (range: 10-68). Bilateral ovarian teratomas were found in 39 patients (11.5%). The mean tumor size was 70.73mm. O-RADS classification 2, 3, and 4 on ultrasound accounted for 80.6%, 11.5%, and 7.9%, respectively. Immature and mature teratomas constituted 2% and 98%, respectively. CA 125 levels increased with higher O-RADS classification; CA 125 and aFP levels were higher in immature teratoma patients compared to mature teratoma patients, with statistically significant differences (p < 0.05). The mean tumor size of the immature teratoma group was larger than that of the mature teratoma group, with a statistically significant difference (p < 0.01). Conclusion: Immature teratomas exhibited larger tumor sizes, higher O-RADS classifications, and elevated levels of tumor markers (Ca125, HE4, aFP).

Article Details

Keywords

Ovarian teratoma, immature teratoma, O-RADS.

References

1. Outwater EK, Siegelman ES, Hunt JL. Ovarian teratomas: tumor types and imaging characteristics. Radiographics. 2001;21(2):475-490.
2. Caruso PA, Marsh MR, Minkowitz S, Karten G. An intense clinicopathologic study of 305 teratomas of the ovary. Cancer. 1971;27(2):343-348.
3. Ray-Coquard I, Trama A, Seckl MJ, et al. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. European Journal of Surgical Oncology. 2019;45(1):67-74.
4. Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of the ovary. Cancer treatment reviews. 2008;34(5):427-441.
5. DiSaia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DG. Clinical Gynecologic Oncology E-Book. Elsevier Health Sciences; 2017.
6. Andreotti RF, Timmerman D, Strachowski LM, et al. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology. 2020;294(1):168-185. doi:10.1148/radiol.2019191150
7. Saleh M, Bhosale P, Menias CO, et al. Ovarian teratomas: clinical features, imaging findings and management. Abdom Radiol (NY). 2021; 46 (6):2293-2307. doi:10.1007/s00261-020-02873-0
8. Kwon HJ. Torsion of ovarian teratoma in a child before menarche. Journal of Pediatric Surgery Case Reports. 2022;77:102170. doi:10.1016/ j.epsc.2021.102170
9. Chun S, Jeon GH, Cho HJ, Ji YI. Comparison Between Incidence of Right- and Left-sided Ovarian Cystic Teratomas. Journal of Reproductive Endocrinology. 2016;4(1):43-48.
10. Trần Thị Phương Mai. Ung thư buồng trứng và vòi Fallopian. In: Bệnh Học Ung Thư Phụ Khoa. NXB Y học; 2005:81-101.